| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 608.41M | 389.14M | 150.61M | 142.41M | 136.69M |
| Gross Profit | 13.91M | 16.54M | 25.53M | 24.57M | 30.08M |
| EBITDA | -54.01M | -21.98M | -3.89M | 4.86M | -11.53M |
| Net Income | -59.01M | -28.42M | -12.72M | -10.32M | -24.99M |
Balance Sheet | |||||
| Total Assets | 213.63M | 206.06M | 218.55M | 238.14M | 216.54M |
| Cash, Cash Equivalents and Short-Term Investments | 55.26M | 39.66M | 39.72M | 36.74M | 19.74M |
| Total Debt | 10.09M | 17.19M | 17.00M | 31.96M | 56.81M |
| Total Liabilities | 98.17M | 73.58M | 74.72M | 97.27M | 78.30M |
| Stockholders Equity | 115.45M | 132.48M | 143.84M | 140.87M | 138.24M |
Cash Flow | |||||
| Free Cash Flow | -22.41M | -47.47M | -8.68M | -11.63M | -18.43M |
| Operating Cash Flow | -7.44M | -35.62M | -2.86M | -10.96M | -12.33M |
| Investing Cash Flow | -14.93M | -10.42M | -4.28M | 45.48M | -5.97M |
| Financing Cash Flow | 37.37M | 46.94M | 10.16M | -17.69M | -1.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$910.27M | 5.23 | 5.84% | 6.04% | -1.81% | -2.23% | |
67 Neutral | HK$2.20B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
63 Neutral | HK$2.19B | 1.51 | 15.14% | 12.14% | -0.95% | 2.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | HK$439.50M | 6.47 | -14.53% | ― | -5.61% | ― | |
49 Neutral | HK$256.88M | -0.50 | -14.46% | ― | -13.96% | -167.54% | |
43 Neutral | HK$294.33M | -9.42 | -40.73% | ― | 56.41% | -77.54% |